The conference will deliberate on various aspects of drug counterfeiting
PatientSafe India, a one-day conference on addressing the counterfeit challenge, will be organised on June 28, 2016 in Mumbai. The conference will be facilitated by SynCore Consulting with the active collaboration of all the industry associations, regulators, trade bodies and consumer groups. The theme of the conference will be to deliberate on various aspects of drug counterfeiting and suggest creative ways to raise awareness and devise strategies for curbing the practice of drug counterfeiting.
The conference will be marked by the presence of eminent speakers from different segments of the pharmaceutical ecosystem. Senior representatives from OPPI, AIOCD, IMA, IPA, IDMA, FDA and various government agencies, directors of policies and government affairs and senior management professionals from the industry will share their insights on tackling the challenge of drug counterfeiting. Delegates from different segments of the pharma industry and from various drug packaging and labelling companies, drug regulatory agencies, security and risk management companies and formulation pharmaceutical manufacturers will mark their presence in this event.
The aim of the initiative is to ensure patient safety by addressing the challenge of drug counterfeiting through programmes such as trade meets, round tables and conferences. The initiative aims to bring together the different stakeholders on a common platform to enable discussions, sharing of insights, best practices and strategies to tackle the drug counterfeit challenge.